Tumor suppressor function of Rab25 in triple-negative breast cancer

被引:79
作者
Cheng, Ji-Ming [1 ,2 ]
Volk, Lisa [2 ,3 ]
Janaki, Deepak Kumar Mummidavarapu [4 ]
Vyakaranam, Sudhir [5 ]
Ran, Sophia [2 ,3 ]
Rao, Krishna A. [1 ,2 ,3 ]
机构
[1] So Illinois Univ, Sch Med, Div Hematol & Oncol, Dept Internal Med, Springfield, IL 62794 USA
[2] SimmonsCooper Canc Inst SIU, Springfield, IL USA
[3] So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62794 USA
[4] Univ Illinois Coll Med Peoria, Dept Internal Med, Peoria, IL USA
[5] Univ Cincinnati, Div Nephrol, Cincinnati, OH USA
关键词
mammary neoplasia; Rab25; p21; RAS; tumorigenesis; apoptosis; ENDOTHELIAL GROWTH-FACTOR; FACTOR VEGF FAMILY; EXPRESSION; CELLS; SPECIFICITY; APOPTOSIS; PATHWAY; MEMBERS; OVARIAN;
D O I
10.1002/ijc.24900
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Rab proteins are a group of ubiquitously expressed proteins that are responsible for intracellular transport of vesicles. Recent evidence has shown that certain Rab proteins are involved in the pathogenesis of cancer. We have recently shown that Rab25 is lost in a large fraction of breast cancer samples, particularly those derived from hormonally insensitive tumors. We have further investigated the role of Rab25 by re-expressing Rab25 in tumorigenic cell lines and measuring the impact on tumor formation as well as on various molecular pathways through PCR array analysis. In vivo tumor growth of cell lines with re-expressed Rab25 was markedly suppressed. Our data suggest that Rab25 acts through multiple pathways to enhance apoptosis and to suppress angiogenesis and invasion by modulating VEGF-A and VEGFR-1 expression. These findings suggest that Rab25 represents a novel class of cellular modulators that can influence both tumor initiation and the progression of the established tumors, thus ultimately affecting the biology of the malignant disease.
引用
收藏
页码:2799 / 2812
页数:14
相关论文
共 50 条
  • [41] Rab25 GTPase: Functional roles in cancer
    Wang, Sisi
    Hu, Chunhong
    Wu, Fang
    He, Shasha
    ONCOTARGET, 2017, 8 (38) : 64591 - 64599
  • [42] Raloxifene reduces triple-negative breast cancer tumor growth and decreases EGFR expression
    Taurin, Sebastien
    Allen, Kirstie M.
    Scandlyn, Marissa J.
    Rosengren, Rhonda J.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 43 (03) : 785 - 792
  • [43] ERRα Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer
    Manna, Subrata
    Bostner, Josefine
    Sun, Yang
    Miller, Lance D.
    Alayev, Anya
    Schwartz, Naomi S.
    Lager, Elin
    Fornander, Tommy
    Nordenskjold, Bo
    Yu, Jane J.
    Stal, Olle
    Holz, Marina K.
    CLINICAL CANCER RESEARCH, 2016, 22 (06) : 1421 - 1431
  • [44] Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer
    Munkacsy, Gyongyi
    Santarpia, Libero
    Gyorffy, Balazs
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
  • [45] Genetic Heterogeneity, Tumor Microenvironment and Immunotherapy in Triple-Negative Breast Cancer
    Kudelova, Eva
    Smolar, Marek
    Holubekova, Veronika
    Hornakova, Andrea
    Dvorska, Dana
    Lucansky, Vincent
    Koklesova, Lenka
    Kudela, Erik
    Kubatka, Peter
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
  • [46] Novel Selenoesters as a Potential Tool in Triple-Negative Breast Cancer Treatment
    Radomska, Dominika
    Czarnomysy, Robert
    Szymanowska, Anna
    Radomski, Dominik
    Dominguez-Alvarez, Enrique
    Bielawska, Anna
    Bielawski, Krzysztof
    CANCERS, 2022, 14 (17)
  • [47] The Anticancer Effects and Therapeutic Potential of Kaempferol in Triple-Negative Breast Cancer
    Kaur, Sukhmandeep
    Mendonca, Patricia
    Soliman, Karam F. A.
    NUTRIENTS, 2024, 16 (15)
  • [48] Dipalmitoylphosphatidic acid inhibits tumor growth in triple-negative breast cancer
    Zhang, Qian-Qian
    Chen, Jian
    Zhou, Da-Lei
    Duan, You-Fa
    Qi, Cui-Ling
    Li, Jiang-Chao
    He, Xiao-Dong
    Zhang, Min
    Yang, Yong-Xia
    Wang, Lijing
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2017, 13 (04): : 471 - 479
  • [49] Functional Proteomic Profiling of Triple-Negative Breast Cancer
    Gromova, Irina
    Espinoza, Jaime A.
    Grauslund, Morten
    Santoni-Rugiu, Eric
    Talman, Maj-Lis Moller
    van Oostrum, Jan
    Moreira, Jose M. A.
    CELLS, 2021, 10 (10)
  • [50] Morphine counteracts the effects of paclitaxel in triple-negative breast cancer cells
    Sezer, Gulay
    Caner, Armagan
    Onal, Muge Gulcihan
    Cumaoglu, Ahmet
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2022, 156 (01) : 70 - 76